We read with interest the article by Karkouti et al. 1 on assessing the use of early postoperative creatinine elevation to identify acute kidney injury (AKI) after cardiac surgery. The AKI was defined based on the consensus recommendations of the AKI Network (AKIN) for serum creatinine (sCr) criteria. The early postoperative sCr change (DCreat ratio ) -denoted as the ratio of postoperative sCr (measured within 30 min of arrival in the intensive care unit)/preoperative sCr -was used as a primary endpoint.
To the Editor,
We read with interest the article by Karkouti et al. 1 on assessing the use of early postoperative creatinine elevation to identify acute kidney injury (AKI) after cardiac surgery. The AKI was defined based on the consensus recommendations of the AKI Network (AKIN) for serum creatinine (sCr) criteria. The early postoperative sCr change (DCreat ratio ) -denoted as the ratio of postoperative sCr (measured within 30 min of arrival in the intensive care unit)/preoperative sCr -was used as a primary endpoint.
It was unclear, however, whether the sCr measured during the early postoperative period had been corrected based on the perioperative fluid balance. Available evidence suggests that not adjusting sCr for the fluid balance could underestimate the true incidence of AKI after cardiac surgery because a positive perioperative fluid balance could dilute sCr. 2 Furthermore, in Karkouti et al.'s study, the threshold of DCreat ratio [ 1.3 was used to identify postoperative AKI. In contrast, Ho et al. 3 demonstrated that a smaller early postoperative sCr change (i.e., C 10% sCr increase) could significantly predict a higher AKI risk, and a C 10% decrease could significantly predict a lower AKI risk compared with the reference category.
In a sensitivity analysis, Karkouti et al. evaluated the relation of the DCreat ratio with AKI stage 1 in the development and validation sets but not the relations of the DCreat ratio with AKI stages 2 and 3. It has been shown that AKI stages 2 and 3 incidences are lower than that of AKI stage 1 and are more significantly associated with short-and long-term adverse outcomes after cardiac surgery. 4 It is thus generally believed that the need for a tool to predict the more severe categories of AKI is important for the patient's prognosis and long-term outcomes after cardiac surgery. 5 Thus, we argue that the predictives value of the DCreat ratio for AKI stages 2 and 3 also require further validation in the development and validation sets.
Finally, several models are available for predicting AKI following cardiac surgery that are based on readilyavailable clinical information before and during surgery. They can be easily applied at the bedside and provide a simple, interpretable estimation of risk. Furthermore, the best-validated models can effectively predict severe AKI that would require dialysis following cardiac surgery, such as the Cleveland Clinic model and the Mehta model. 5 In Karkouti et al.'s study, the sensitivity, specificity, and positive and negative predictive values for using a threshold ratio of DCreat ratio [ 1.3 for predicting postoperative AKI in the development set were 20% (95% confidence interval [CI], 16 to 24), 99% (95% CI, 99 to 99), 68% (95% CI, 59 to 76), and 93% (95% CI, 92 to 93), respectively. As Karkouti et al.'s study design did not include evaluation of the discrimination ability of DCreat ratio compared with the best-validated clinical models to identify the patients who suffer AKI, an important question remains unanswered: Does the information gained from the DCreat ratio facilitate early identification of AKI after cardiac surgery as well as, or better than the clinical models?
